Page last updated: 2024-10-31

metyrapone and Retroperitoneal Neoplasms

metyrapone has been researched along with Retroperitoneal Neoplasms in 1 studies

Metyrapone: An inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME.
metyrapone : An aromatic ketone that is 3,3-dimethylbutan-2-one in which the methyl groups at positions 1 and 4 are replaced by pyridin-3-yl groups. A steroid 11beta-monooxygenase (EC 1.14.15.4) inhibitor, it is used in the diagnosis of adrenal insufficiency.

Retroperitoneal Neoplasms: New abnormal growth of tissue in the RETROPERITONEAL SPACE.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Morimoto, Y1
Hiwada, K1
Nanahoshi, M1
Yano, S1
Kumagai, A1
Yamamura, Y1
Koto, K1
Uda, H1
Okano, K1
Yamane, G1

Other Studies

1 other study available for metyrapone and Retroperitoneal Neoplasms

ArticleYear
Cushing's syndrome caused by malignant tumor in the scrotum: clinical, pathologic and biochemical studies.
    The Journal of clinical endocrinology and metabolism, 1971, Volume: 32, Issue:2

    Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adrenal Rest Tumor; Adrenocorticotropic Hormone; Androst

1971